Beyond relapses: How BTK inhibitors are shaping the future of progressive MS treatment.
Saved in:
| Title: | Beyond relapses: How BTK inhibitors are shaping the future of progressive MS treatment. |
|---|---|
| Authors: | Naydovich LR; Department of Neurology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, USA. Electronic address: laura.naydovich@pennmedicine.upenn.edu., Orthmann-Murphy JL; Department of Neurology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, USA. Electronic address: Jennifer.Orthmann-Murphy@pennmedicine.upenn.edu., Markowitz CE; Department of Neurology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, USA. Electronic address: cmarkowi@pennmedicine.upenn.edu. |
| Source: | Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics [Neurotherapeutics] 2025 Jul; Vol. 22 (4), pp. e00602. Date of Electronic Publication: 2025 May 08. |
| Publication Type: | Journal Article; Review |
| Journal Info: | Publisher: Elsevier Inc. on behalf of American Society for Experimental NeuroTherapeutics Country of Publication: United States NLM ID: 101290381 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1878-7479 (Electronic) Linking ISSN: 18787479 NLM ISO Abbreviation: Neurotherapeutics Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
